Back to search results

Gender Related Coping and Survivorship for Bladder Cancer

This study is looking at how women with bladder cancer cope and live with their disease, focusing on emotional distress and sexual health. Researchers want to see if extra education and support can help improve these areas. You would be asked to complete surveys about your mood and sexual function. Some participants will also receive extra educational materials, counseling, and referrals to support groups. The study aims to see if these additional resources can help reduce feelings of demoralization (a sense of hopelessness) and improve sexual function. This is an observational study, meaning researchers will gather information without giving new treatments. The study is currently unclear on its recruitment status and is looking for 80 women with bladder cancer.

Study design
This is an observational study that will enroll 80 women with bladder cancer. Participants will be randomly assigned to either a standard care group or an education group.
What's involved
You would complete surveys about your mood and sexual health at the start, and then at 1, 3, 6, and 12 months after treatment. If you are in the education group, you would also complete attendance diaries for educational and support services.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year after treatment, with assessments at 1, 3, 6, and 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05649306

Gender Related Coping and Survivorship for Genitourinary Cancers

Recruiting
Not specifiedAges 18+Observational
Johns Hopkins University
~80 participants
Updated 2025-10-03 on ClinicalTrials.gov
What's tested:Additional EducationQuestionnairesAttendance Diary

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Use Demoralization Scale-II to assess change in demoralization
Measured over Baseline, 1-Month after Treatment, 3-Months after Treatment, 6-Months after Treatment, 1-year after Treatment

Conditions

Bladder Cancer

Explore related trials

Bladder Carcinoma

NCT05649306

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Johns Hopkins Hospital

    Baltimore, Marylandstudy coordinator listed

    Recruiting

  • Sibley Memorial Hospital

    Washington D.C., District of Columbiastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Armine Smith, MD · PRINCIPAL_INVESTIGATOR · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Who to contact

Meghan McNamara
[email protected]
202-660-6133
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Females with bladder cancer
Willing to answer surveys regarding their psychosocial health and sexual health

Exclusion

Not undergoing either active treatment or active surveillance (i.e. patients on hospice care)
Patients with cognitive impairments
Women who are pregnant

What this trial measures

  • Use Demoralization Scale-II to assess change in demoralizationBaseline, 1-Month after Treatment, 3-Months after Treatment, 6-Months after Treatment, 1-year after Treatment

    Evaluate educational interventions to improve demoralization in females with bladder cancer. The minimum score is 0 and the maximum score 32. Low scores are defined as 0-3, middle scores are defined between 4-10, and high scores are defined as ≥11.